^
+ Follow ELI LILLY PHILS Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1255962
                    [Title] => FDA recalls unregistered erectile dysfunction drug
                    [Summary] => 

The Food and Drug Administration (FDA) has ordered the recall of Cialis (generic name tadalafil) 20-milligram tablet, a drug for erectile dysfunction that was found to be unregistered.

[DatePublished] => 2013-11-13 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1804896 [AuthorName] => Sheila Crisostomo [SectionName] => Metro [SectionUrl] => metro [URL] => ) [1] => Array ( [ArticleID] => 235415 [Title] => Eli Lilly Philippines bares restructured operations [Summary] => Eli Lilly Phils. has announced a reorganization of its operations in the Philippines.

The restructuring includes a reorganization of resources and a reduction in the work force to reflect significant changes in the Philippine market and in its product mix. Henceforth, Pharmalink, a division of Zuellig Pharma Inc. will market the retail products Axid, Ceclor, Dobutrex, Ilosene, Keflex, Tapazole and Vancocin.
[DatePublished] => 2004-01-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Business [SectionUrl] => business [URL] => ) ) )
ELI LILLY PHILS
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1255962
                    [Title] => FDA recalls unregistered erectile dysfunction drug
                    [Summary] => 

The Food and Drug Administration (FDA) has ordered the recall of Cialis (generic name tadalafil) 20-milligram tablet, a drug for erectile dysfunction that was found to be unregistered.

[DatePublished] => 2013-11-13 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1804896 [AuthorName] => Sheila Crisostomo [SectionName] => Metro [SectionUrl] => metro [URL] => ) [1] => Array ( [ArticleID] => 235415 [Title] => Eli Lilly Philippines bares restructured operations [Summary] => Eli Lilly Phils. has announced a reorganization of its operations in the Philippines.

The restructuring includes a reorganization of resources and a reduction in the work force to reflect significant changes in the Philippine market and in its product mix. Henceforth, Pharmalink, a division of Zuellig Pharma Inc. will market the retail products Axid, Ceclor, Dobutrex, Ilosene, Keflex, Tapazole and Vancocin.
[DatePublished] => 2004-01-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Business [SectionUrl] => business [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with